[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO2012025229A8 - Composition and method of manufacture - Google Patents

Composition and method of manufacture Download PDF

Info

Publication number
WO2012025229A8
WO2012025229A8 PCT/EP2011/004254 EP2011004254W WO2012025229A8 WO 2012025229 A8 WO2012025229 A8 WO 2012025229A8 EP 2011004254 W EP2011004254 W EP 2011004254W WO 2012025229 A8 WO2012025229 A8 WO 2012025229A8
Authority
WO
WIPO (PCT)
Prior art keywords
age
reducing
combination
progression
vitamin
Prior art date
Application number
PCT/EP2011/004254
Other languages
French (fr)
Other versions
WO2012025229A1 (en
Inventor
Mahmood Piraee
Original Assignee
Persavita Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1014340.2A external-priority patent/GB201014340D0/en
Application filed by Persavita Ltd. filed Critical Persavita Ltd.
Priority to GB1305581.9A priority Critical patent/GB2498660B/en
Priority to CA2809071A priority patent/CA2809071C/en
Priority to US13/819,173 priority patent/US9486464B2/en
Priority to AU2011295398A priority patent/AU2011295398B2/en
Publication of WO2012025229A1 publication Critical patent/WO2012025229A1/en
Publication of WO2012025229A8 publication Critical patent/WO2012025229A8/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Botany (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

A dietary supplement composition comprises a synergistic combination of saffron and resveratrol for providing anti-oxidant and gene modulation effects for preventing, ameliorating and/or reducing a rate of development and progression of age-related macular degeneration (AMD). Optionally, the combination is supplemented with one or more further ingredients: fish oil, Zinc, Copper, vitamin C, vitamin E, lutein, zeaxanthin. The combination is beneficially provided as a composition which is useful for reducing a risk of developing, and/or for reducing a rate of progression of age-related macular degeneration, and/or for preventing age-related sight loss, and other age-related diseases.
PCT/EP2011/004254 2010-08-27 2011-08-25 Composition and method of manufacture WO2012025229A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GB1305581.9A GB2498660B (en) 2010-08-27 2011-08-25 A composition comprising resveratrol and saffron
CA2809071A CA2809071C (en) 2010-08-27 2011-08-25 Composition and method of manufacture
US13/819,173 US9486464B2 (en) 2010-08-27 2011-08-25 Composition and method of manufacture
AU2011295398A AU2011295398B2 (en) 2010-08-27 2011-08-25 Composition and method of manufacture

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB1014340.2 2010-08-27
GBGB1014340.2A GB201014340D0 (en) 2010-08-27 2010-08-27 Nutritional supplement formulation comprising saffron and resveratrol
GBGB1100925.5 2011-01-19
GB1100925.5A GB2483121A (en) 2010-08-27 2011-01-19 Composition comprising resveratrol and saffron

Publications (2)

Publication Number Publication Date
WO2012025229A1 WO2012025229A1 (en) 2012-03-01
WO2012025229A8 true WO2012025229A8 (en) 2012-10-11

Family

ID=45722920

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2011/004254 WO2012025229A1 (en) 2010-08-27 2011-08-25 Composition and method of manufacture

Country Status (1)

Country Link
WO (1) WO2012025229A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201014340D0 (en) 2010-08-27 2010-10-13 Piraee Mahmood Nutritional supplement formulation comprising saffron and resveratrol
FR2995185A1 (en) * 2012-09-13 2014-03-14 Mundema Edible composition, useful as a soothing agent for treating obesity, comprises a flower extract of Crocus sativus having specified particle size and specified safranal content
ES2732307T3 (en) * 2013-06-13 2019-11-21 Smartfish As A marine oil formulation comprising resveratrol or derivatives thereof for use in the treatment, delay and / or prevention of Alzheimer's disease

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63109788A (en) 1986-06-06 1988-05-14 Ajinomoto Co Inc Production of safranal, crocin or analog thereof
US5654003A (en) 1992-03-05 1997-08-05 Fuisz Technologies Ltd. Process and apparatus for making tablets and tablets made therefrom
CN1059444C (en) 1994-11-29 2000-12-13 中国药科大学 Composition for curing angicardiopathy and its production and usage
US6573299B1 (en) * 1999-09-20 2003-06-03 Advanced Medical Instruments Method and compositions for treatment of the aging eye
US20090169585A1 (en) 2003-10-23 2009-07-02 Resveratrol Partners, Llc Resveratrol-Containing Compositions And Their Use In Modulating Gene Product Concentration Or Activity
ITRM20050446A1 (en) * 2005-08-19 2007-02-20 Tubilux Pharma S P A USE OF HYDROXYLATED AND GLUCOSIDATED STYLBENES FOR THE PREVENTION AND TREATMENT OF EYE PATHOLOGIES.
CN101062339A (en) 2007-05-23 2007-10-31 魏荣祥 Medicine for treating diabetes
CN101514216B (en) 2008-02-22 2012-05-23 四川大学 Synthesis method of saffron glucoside
CN101361892B (en) * 2008-10-09 2011-04-06 陕西东泰制药有限公司 Traditional Chinese medicine formulation for treating cataract and preparation method thereof
JP2010195779A (en) 2009-02-18 2010-09-09 Omnica Gmbh Hydrolysate of crocin
CN101597554A (en) 2009-06-16 2009-12-09 赵宇 The thick wine of one kind of plant

Also Published As

Publication number Publication date
WO2012025229A1 (en) 2012-03-01

Similar Documents

Publication Publication Date Title
GB2498660A (en) Composition and method of manufacture
TN2009000241A1 (en) Nutritional supplement composition for treatment of ocular diseases
WO2007076416A3 (en) Composition and methods for inhibiting the progression macular degeneration and promoting healthy vision
EP3085365A3 (en) Synergistic combinations of carotenoids and polyphenols
WO2012106582A3 (en) Confection composition
PH12016501914A1 (en) Effect of lipophilic nutrients on diabetic eye diseases
WO2012013861A3 (en) Use of blood group status iii
WO2009047644A3 (en) Method of treating vitamin d insufficiency and deficiency
WO2007114945A3 (en) Compositions and methods for enhancing the antioxidant status of animals
MX2010004154A (en) Fish food capsule
WO2009037562A3 (en) Nutritional supplement formulations and fortified foods comprising such supplements
JP2014524914A5 (en)
WO2012025229A8 (en) Composition and method of manufacture
EP2522226A3 (en) Composition for the preserving of caviare from fish grown in aquaculture
BR112014000182A2 (en) bitterness masking
WO2006117826A3 (en) Composition comprising olive oil enriched and supplemented with lutein
PH12017500357A1 (en) Lactic acid bacteria-containing composition
WO2013007447A3 (en) Edible composition
CL2011003235A1 (en) Fish food containing at least one water-soluble antioxidant selected from the group hydroxycinnamic acids or hydrobenzoic acids, contains up to 40 mg of pigment per kilogram of food of at least one pigment selected from the group comprising astaxanthin or canthaxanthin.
EP3826630A4 (en) Cannabinoids compositions with polyunsaturated fatty acid monoglycerides, methods and uses thereof
AU2011363023A8 (en) Reduced sodium salt composition
CL2009000230A1 (en) Nutritional or dietary supplement composition comprising vitamin C, vitamin E, lutein, zinc, omega 3 fatty acids and copper; manufacturing method; use for the treatment and / or prevention of age-related macular degeneration and diabetic retinopathy.
ATE397389T1 (en) FORMULATION FOR ORAL ADMINISTRATION WITH HEALTH-PROMOTING EFFECTS ON THE CARDIOVASCULAR SYSTEM
MY188896A (en) Methods and compositions for reducing digestive/absorptive rates and ratio of food/drinks or reducing a digestive solution
WO2011076557A8 (en) Use of canthaxanthin and/or 25-oh d3 for improved reproductivity and performance of roosters

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11754999

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase in:

Ref document number: 2809071

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 13819173

Country of ref document: US

NENP Non-entry into the national phase in:

Ref country code: DE

ENP Entry into the national phase in:

Ref document number: 1305581

Country of ref document: GB

Kind code of ref document: A

Free format text: PCT FILING DATE = 20110825

WWE Wipo information: entry into national phase

Ref document number: 1305581.9

Country of ref document: GB

ENP Entry into the national phase in:

Ref document number: 2011295398

Country of ref document: AU

Date of ref document: 20110825

Kind code of ref document: A

122 Ep: pct application non-entry in european phase

Ref document number: 11754999

Country of ref document: EP

Kind code of ref document: A1